Welcome to the Iron coli Project Home Page

Authors

E. van der Kouwe^{1, 2}, G. Mercy³, B. Baudu⁴, A. Chhun¹, F. Amiot¹, G. Guillocheau¹, L. Le Goff⁵, H. Léger⁵, L. Ujéda^6,7, W. Rostain⁸, C. Pauthenier⁹, T. Cerisy¹⁰, P. Parutto⁹, A. Jaramillo⁸, A. Tolonen¹⁰ and N. Pollet¹¹

Abstract

This year, our project focuses on hematological disorders. More specifically, we focus on diseases that are subsequent to an iron overload such as hemochromatosis and thalassemia. For hereditary hemochromatosis, the symptoms are due to the overabsorption of iron from the duodenum by the mutation of the HFE protein. However, in case of thalassemia, patients excessively absorb iron because of a subsequent metabolic perturbation.

Nowadays, the iron overload is mainly treated by bloodlettings for hemochromatosic patients but cannot be extended to thalassemic patients who suffer from anaemia. The aim of our project is to prevent the intestinal absorption of iron, thus acting directly at the source.

Using the Ferric Uptake Regulation (FUR) system that controls siderophore biosynthesis (iron chelator), we engineer Escherichia coli in order to produce these siderophores in response of high concentrations of iron. To reduce the patient's iron absorption, our bacteria will be placed in a capsule and will be ingested during a meal. Once it will arrive in the duodenum, our bacteria will produce the siderophore at their full potential and chelate the iron.

Affiliations

¹Université Evry Val d'Essonne

²Faculté de Pharmacie de Lyon

³Sup'Biotech Paris

⁴AgroParisTech

⁵Ecole Nationale Supérieure d'Informatique pour l'Industrie et l'Entreprise

⁶Sciences Po Paris

⁷Paris-Descartes

⁸Synth Bio Team, Institute of Systems and Synthetic Biology

⁹Bio-RetroSynth Team, Institute of Systems and Synthetic Biology

¹⁰LGBM, Genoscope

¹¹Metamorphosys, Institute of Systems and Synthetic Biology